pagiantmetknicksfan@yahoo.com
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
That is huge news.
Covered this last night but let's see. Insiders sold a couple percent of their holdings and the Chairman increased his position 200% at $600k out of his pocket. hmmm
Now have folks been selling into the bid and trying to get others to sell....hmmm...pretty obvious I would say right...
The CEO told you this on the last conference call. All should check it out or read the transcript. They have to pay Elite for every product they submit to transfer and then get each of Elite's 11 FDA approved drugs to market. But they can only sell so much as allowed and they have 70m plus shares....It costs money to transfer 11 FDA drugs. Big revenue coming to Elite with basically no costs.
Then again, it certainly didn't stop the Chairman from buying 6m shares last week when he just could have collected 10% interest instead.
I am going to bet the Chairman knows what he is doing with his $600k. Now I could believe what some would like me too but something tells me the Chairman of the board has his own best interests at stake here.
The CEO told you this on the last conference call. All should check it out or read the transcript. They have to pay Elite for every product they submit to transfer and then get each of Elite's 11 FDA approved drugs to market. But they can only sell so much as allowed and they have 70m plus shares....It costs money to transfer 11 FDA drugs. Big revenue coming to Elite with basically no costs.
Then again, it certainly didn't stop the Chairman from buying 6m shares last week when he just could have collected 10% interest instead.
I am going to bet the Chairman knows what he is doing with his $600k. Now I could believe what some would like me too but something tells me the Chairman of the board has his own best interests at stake here.
The most important thing about the study so many of us long investors have seen is that it means that Elite will pass the muster of abuse deterrence. The level that Purdue had will be exceeded which is so important. We all knew this already because, again simple science is at play here so no surprise at the results
However when you consider what happened with Endo, you can read the tea leaves regarding the FDA process. This study certainly tells you that Elite is in rare air here.
So exciting that these two quick pilot studies are going off so quickly and then into the larger studies already scheduled. Tells you they believe in the product but then again the chairman bought 6m shares about a week ago so again, no surprise there.
Honestly the question is not whether there is a link. I think most understand that there is and the data is real because it is simple science. Pharmacological approach is going to come out on top and is the best approach. Heck I think even Nasrat told you about this before and about a similar type of study that was also commissioned. The question you need to ask is what else is out there? What did I miss? As an investor would it make sense for me to just put everything I know out there for public consumption?
Company is making all the right moves. Everyone gets that now. talk soon
That is really great because it shows how confident the company was back then before the market crashed and they ran out of money. The tech works, But that is not the new data, heck that is not even the old study data but thanks for reminding us that this tech is very real. Elite was truly ahead of their time
Yeah again talking about efficacy which had nothing to do with my posts nor the study cited. And again disregarding basic science anyway. And to clear up some items here
I can present a link, I just choose not to which is my choice. Now the question becomes, do I care if people here believe me? Obviously I don't.
The trials are for Bio-equivalence and have nothing to do with the desire to abuse the drug. I can't really explain that much more clearly.
And gain, I don't care whether you believe me or not. In fact the only thing being miss characterized here is what I have stated....
Relax. The data isn't a secret. And the drugs have to go through trials but I have explained the purpose of the study and what the results were. It is public information that can be accessed. You keep bringing up efficacy and approvals and things completely unrelated to the subject at hand.
Bottom line is that the study exists, Oxy/Nal is noted as being least desirable for abuse purposes and based on simple science, this is to be expected anyway. Anyone in the field would get this. In fact there is similar data out there from older research that showed the same thing. Elite has been around a long time and the tech has always been solid. Just bad mgmt. and no money. Now great management and money. Heck the Chairman just bought 6m shares.
How about the two products entering pilot BE studies now? Pretty awesome huh? You think partnership before or after..lol...good times.
LOL. You think I care is the funniest part. Those that know....know and have seen it....If your background is such, then you would understand the science which makes the whole thing rather obvious without the study....a study that shows Oxy/Nal being more of a deterrent to abuse than Purdues Oxy. Really for someone in the field this would just be common sense.
And what you you should be asking is, if no one has posted this information before, what else is out there no one has discussed....hmmmmmmm
I have distributed it to the long investors I could verify and was able to contact that asked me to.
Oxy/Nal rated higher, the highest actually in a peer reviewed journal in a study done by actual doctors. Published this year. Just because someone hasn't seen it, does not make it true.
Many have access to it and have seen it. It is simple science though so it is not really a surprise and most longs already understand this is a superior methodology already. The CEO noted this multiple times.
And no one said anything about efficacy which is not really the point
I agree with a lot of what you just posted actually. But this is what it is....Maybe I have low expectations to begin with but I can be damned sure I would have asked questions if I had money on the line. However some of what you posted is nonsense too especially about filling the audience with a few people from home furnishings store or whatever....
And I agree with zomniac too here. If IPTV is dead, then so is SWRF but I don't think that is going to be the case. And mgmt here is sketchy. See my post about checking for my wallet...
Standyby MRWRN
I posted this yesterday and yet none asked....
Interesting but a couple problems with what you just posted
Here is the biggest one
First you note that only softball questions were asked...as reported by your two colleagues....Well if that was the case, how come your two colleagues didn't ask any questions? hmmmmmm? Were they just there for the food? This puts the rest of what you note as suspicious to say the least.
Secondly what does home furnishing employees have to do with anything? There are pictures of the place and you note it was a nice place so what are you talking about?
Regarding the crowd, it is what it is, the stock trades for .00x, I have no idea what type of crowd you would expect.
NO FINANCIAL INFORMATION given out....Yeah that would be illegal wouldn't it?
I think there is a lot to wonder about here but what you posted sounds sketchy to me
You are half correct OxyNal is not an approved product. The rest is incorrect. There is most certainly a study that covers OxyNal and compares it to a number of products including new OXY from Purdue.
Let me add that it is a published study, this year, not that long ago actually
And it seems people that were actually there disagree
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=94669066
hmmmmmmmm.......
Really? What was your source because by all accounts that is a pretty incorrect and sort of baseless statement. It also seems that the technology works as advertised. I am as critical as anyone but when you can go look at pictures from the affair which seem like a pretty classy get together actually, it seems pretty silly to say it was a dismal affair. It was a meet and greet for interested investors in a Midwest city for a stock that trades .00x
Have you ever been to one of these things? What do you think it would be? A Tony Robbins seminar?
That is a bit presumptuous. I would say there are quite a few that can produce the study. There are so many things not discussed here you can't possibly imagine.
BTW this study was done this year....
If any actual investors need a link to these scientific publications, let me know but to get much of the details you will also need a paid subscription. It is for actual Doctors and scientists.
A published Panel Survey has already concluded that OxyNal is better at deterrence and drug "liking" over the competitors...including new Oxy from Purdue
Got DD? LOL LOL
That pic makes me want to check to make sure my wallet is still in my pocket....
I think this stock is going to go for a nice run soon but there is so much that is shady about these companies, it is certainly fascinating..
Some questions
Why does the swordfish website still show the Radio Shack nonsense?
How can the IPTV deal be dead. Clark is IPTV, you all realize that right?
And being partnered with Eddie Vakser? Next meeting, get together ask Eddie where the Picasso statue is...They are playing the same game here...
And how come all the news that relates to SWRF and TDEY is only PR'd under TDEY? It never shows up on SWRF even though the ticker is in the PR.
Are we still on track for $47m in revenue next year? lol
Poorme,
Simple question. How many ART products are in development, what are they and how many are scheduled for trials?
Howe many shares do you think have been accumulated by large outside parties by now?
Ohhh noo..lol
The chairman just bought 6 million shares.....
Do your DD...
Trials start this week
Dr L
Should people be buying shares and putting them away for now? Would it be a good investment?
Really there are two categories
Buyers
Holders
Some sold and are buying back. Some work for those accumulating. Some are just traders and flippers...but all are ultimately buyers.
Slapy, there are no shorts. That has been the case for a long time now. There are people that have sold, people that are accumulating, people that are holding. That has become obvious.
Dr L.
Should people be buying this stock and putting it away for now?
Dr L.
Should people be buying this stock and putting it away for now?
So what are the products, how many competitors, and what are the markets.........trials start next week....
Can anyone tell me some market caps of companies with over 20 FDA approved drugs?
Not counting all the drugs in the pipeline and ART.....just 20 Approved drugs
It is actually four ART products.......
Anyone looking for actual factual information about Elite, Drug trials that start in about 2 weeks, operations, Operating profit, Mgmt, drug transfers and launches, why Epic sold some shares etc... (hint - it has nothing to do with much of what has been mentioned and is about funding 12 drug filings, all of which require payments to Elite) Also Epic is restricted in how many shares they can sell.
Trial enrollment started...to begin shortly, 3 different ART Oxy ART products....
Have been in discussion with major Pharmaceutical companies.
Many other products including the first ANDA with only one competitor....
Here is the link to the CC replay
http://www.elitepharma.com/investor_relations.asp?goto=369
Anyone looking for factual information about Elite, Drug trials that start in about 2 weeks, operations, Operating profit[color=red][/color], Mgmt, drug transfers and launches, why Epic sold some shares etc... (hint - it has nothing to do with much of what has just been mentioned and is about funding 12 drug filings, all of which require payments to Elite) Also Epic is restricted in how many shares they can sell.
Trial enrollment started...to begin shortly, 3 different ART Oxy ART products....
Have been in discussion with two major Pharmaceutical companies.
Many other products including the first ANDA with only one competitor....
Here is the link to the CC replay
http://www.elitepharma.com/investor_relations.asp?goto=369
Anyone looking for factual information about Elite, Drug trials that start in about 2 weeks, operations, Operating profit, Mgmt, drug transfers and launches, why Epic sold some shares etc... (hint - it has nothing to do with much of what has just been mentioned and is about funding 12 drug filings, all of which require payments to Elite) Also Epic is restricted in how many shares they can sell.
Trial enrollment started...to begin shortly, 3 different ART Oxy ART products....
Have been in discussion with two major Pharmaceutical companies.
Many other products including the first ANDA with only one competitor....
Here is the link to the CC replay
http://www.elitepharma.com/investor_relations.asp?goto=369
Speculation? on the drug that was named on a CC....What is the speculation part? Repeating the name or repeating that that there is little competition as noted on the CC. Anyway gotta go...
If any posts pop up that discuss what is actually going on at the company I may respond later.
If you say so. Just tell me the name of the ANDA with Epic that is being referred then and how many competitors it has.
I skimmed though most the posts and was trying to find the one about what the company is actually doing....took awhile but I found a couple....Trials start shortly...